⚕ GalenOps CRO console
← 717 (USA)

717-1446

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 717 (USA) (Dr. Reyes) · consented 2013-09-01
Adverse events
9
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild ANXIETY — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-15 (study day 15.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild ANXIETY — outcome: RECOVERED/RESOLVED; onset 2013-09-15 (study day 15.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate PAIN — outcome: RECOVERED/RESOLVED; onset 2014-01-13 (study day 135.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate PAIN — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-28 (study day 150.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-07 (study day 37.0); relationship: REMOTE

mild assessed 2026-08-18

Mild RASH — outcome: RECOVERED/RESOLVED; onset 2013-10-07 (study day 37.0); relationship: REMOTE

mild assessed 2026-08-18

Mild SINUS BRADYCARDIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-06 (study day 36.0); relationship: REMOTE

mild assessed 2026-08-18

Mild SINUS BRADYCARDIA — outcome: RECOVERED/RESOLVED; onset 2013-10-06 (study day 36.0); relationship: REMOTE

moderate assessed 2026-08-18

Moderate SKIN IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-19 (study day 19.0); relationship: POSSIBLE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.